PRL and adenoma: The identification of estrogen metabolites and 17-ketosteroids in the urine of patients with PRL-secreting adenomas is most likely to be due to decreased activity of 3 beta-hydroxysteroid dehydrogenase and 5α-reductase that occurs among these patients (66).